Advanced Search
Contact | Corporate | Help

Dasatinib, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer

Sponsors:
  • M.D. Anderson Cancer Center
  • National Cancer Institute (NCI)
Phases:
IndicationsAcronym:
  • Endometrial Cancer
Age Groups:
  • Adult
  • Senior
Gender:
Female
Names:
  • Drug: carboplatin
  • Drug: dasatinib
  • Drug: paclitaxel
  • Genetic: gene expression analysis
  • Other: laboratory biomarker analysis
Enrollment:
15

Additional information about NCT01440998.


SourceSolution © 2008-2012